Skip Navigation


International Immunology Advance Access originally published online on December 20, 2006
International Immunology 2007 19(2):133-140; doi:10.1093/intimm/dxl130
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/2/133    most recent
dxl130v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yang, G.
Right arrow Articles by Zhang, J. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, G.
Right arrow Articles by Zhang, J. Z.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2006. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B

Guilin Yang1,2, Ailian Liu1, Qing Xie3, Taylor B. Guo1, Bing Wan1, Boping Zhou2 and Jingwu Z. Zhang1,4,5

1 Joint Immunology Laboratory of Institute of Health Sciences and Shanghai Institute of Immunology, Shanghai Jiao-Tong University School of Medicine and Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China
2 Shenzhen Municipal Hospital of Infectious Diseases, Shenzhen, China
3 Department of Infectious Diseases, Rui-Jin General Hospital, Shanghai, China
4 Immunology Divsion, E-Institutes of Shanghai Universities, China
5 Present address: Institute of Health Sciences, 225 South Chongqing Road, Shanghai 200025, China

Correspondence to: J. Z. Zhang; E-mail: jzang{at}bcm.tmc.edu

Chronic activity of hepatitis B is thought to involve aberrant immune tolerance of unknown mechanism. In this study, we examined the role of CD4+CD25+Foxp3+ regulatory T cells in disease activity and viral clearance in hepatitis B. Patients with chronic active hepatitis B (CAH) and asymptomatic HBV carriers (AsC) exhibited a significantly high frequency of CD4+CD25+Foxp3+ T cells as opposed to that of controls and resolved HBV infection. These CD4+CD25+ T cells expressed an elevated level of Foxp3 and displayed increased inhibitory activity towards both CD4+CD25– and CD8+ effector cells. They were found to accumulate in liver biopsy tissue of CAH patients as opposed to controls. The frequency of CD4+CD25+Foxp3+ T cells correlated positively with hepatitis B envelope (HBe) antigen status and serum HBV DNA copy numbers and had a converse relationship with HBe antibody status in patients with CAH and AsC. It was evident that in these patients, the increased frequency of CD4+CD25+Foxp3+ T cells was associated with serum levels of transforming growth factor-ß known to promote peripheral conversion of CD4+CD25– T cells to CD4+CD25+Foxp3+ regulatory T cells. The findings provide new insights into the role of CD4+CD25+Foxp3+ regulatory T cells in chronic activity and viral clearance in chronic hepatitis B.

Keywords: CD4+CD25+ regulatory T cells, hepatitis B, TGF-ß, transcription factor Foxp3

Transmitting editor: C. J. Paige


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Virol.Home page
S. Li, E. J. Gowans, C. Chougnet, M. Plebanski, and U. Dittmer
Natural Regulatory T Cells and Persistent Viral Infection
J. Virol., January 1, 2008; 82(1): 21 - 30.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.